Exploring the insulin secretory properties of the PGD2-GPR44/DP2 axis in vitro and in a randomized phase-1 trial of type 2 diabetes patients.
Stanko SkrticBjörn TyrbergMalin BrobergHans EricssonVolker SchneckeMagnus KjaerMarcus HompeschEva-Marie AnderssonErik RybergAlexander AivazidisCharlotte Wennberg HuldtLars LöfgrenLinda MorrowJoanna ParkinsonTina Rydén-BergstenElaine WatkinsMaria Sörhede WinzellPublished in: PloS one (2018)
ClinicalTrials.gov NCT02367066.